# Can Intrauterine Levonorgestrel Releasing Device Be a Treatment Option for Postmenstrual Spotting in Isthmocele

> **NCT04872244** · NA · COMPLETED · sponsor: **Gaziosmanpasa Research and Education Hospital** · enrollment: 30 (actual)

## Conditions studied

- Isthmocele
- Post-menstrual Spotting Bleeding
- Pelvic Pain

## Interventions

- **DEVICE:** usage of mirena ( levonorgestrel releasing intrauterine device) in isthmocele
- **DRUG:** Levonorgestrel Drug Implant Product

## Key facts

- **NCT ID:** NCT04872244
- **Lead sponsor:** Gaziosmanpasa Research and Education Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-03
- **Primary completion:** 2021-06-03
- **Final completion:** 2021-07-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04872244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04872244, "Can Intrauterine Levonorgestrel Releasing Device Be a Treatment Option for Postmenstrual Spotting in Isthmocele". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04872244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*